1. Swanson A, Ramos E, Snyder H. Next generation sequencing is the impetus for the next generation of laboratory-based genetic counselors. J Genet Couns 2014; 23: 647-654. [
DOI:10.1007/s10897-013-9684-1]
2. Henneman L, Timmermans DR, Van Der Wal G. Public attitudes toward genetic testing: perceived benefits and objections. Genet Test 2006; 10: 139-145. [
DOI:10.1089/gte.2006.10.139]
3. Senior V, Marteau TM, Peters TJ. Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Soc Sci Med 1999; 48: 1857-1860. [
DOI:10.1016/S0277-9536(99)00099-4]
4. Lesko LJ, Schmidt S. Clinical implementation of genetic testing in medicine: a US regulatory science perspective. Br J Clin Pharmacol 2014; 77: 606-611. [
DOI:10.1111/bcp.12299]
5. Aro AR, Hakonen A, Hietala M, Lonnqvist J, Niemela P, Peltonen L, et al. Acceptance of genetic testing in a general population: age, education and gender differences. Patient Educ Couns 1997; 32: 41-49. [
DOI:10.1016/S0738-3991(97)00061-X]
6. Levitt DM. Let the consumer decide? The regulation of commercial genetic testing. J Med Ethics 2001; 27: 398-403. [
DOI:10.1136/jme.27.6.398]
7. Gaskell G, Bauer MW, Durant J, Allum NC. Worlds apart? The reception of genetically modified foods in Europe and the U.S. Science 1999; 285: 384-387. [
DOI:10.1126/science.285.5426.384]
8. Gaskell G, Allum N, Bauer M, Durant J, Allansdottir A, Bonfadelli H, et al. Biotechnology and the European public. Nat Bbiotechnol 2000; 18: 935-938. [
DOI:10.1038/79403]
9. Etchegary H. Public attitudes toward genetic risk testing and its role in healthcare. Per Med 2014; 11: 509-522. [
DOI:10.2217/pme.14.35]
10. Haga SB, Barry WT, Mills R, Ginsburg GS, Svetkey L, Sullivan J, et al. Public knowledge of and attitudes toward genetics and genetic testing. Genet Test Mol Biomarkers 2013; 17: 327-335. [
DOI:10.1089/gtmb.2012.0350]
11. Henneman L, Vermeulen E, van El CG, Claassen L, Timmermans DR, Cornel MC. Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010. Eur J Hum Genet 2013; 21: 793-799. [
DOI:10.1038/ejhg.2012.271]
12. Mokhtari R, Bagga A. Consanguinity, genetic disorders and malformations in the Iranian population. Acta Biologica Szegediensis 2003; 47: 47-50.
13. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, et al. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25: 285-296. [
DOI:10.1081/HEM-100105221]
14. Hosseini SH, Gaffari Saravi W, Hashemi Soteh SMB, Zarghami M, Saljughian A. Evaluation of co-segregation between bipolar mood disorder and heterozygous beta thalassemia in patients originated from Iran. Res J Biol Sci 2008; 3: 798-800.
15. Najmabadi H, Ghamari A, Sahebjam F, Kariminejad R, Hadavi V, Khatibi T, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet 2006; 9: 93-97. [
DOI:10.1159/000091486]
16. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007; 29: 233-238. [
DOI:10.1097/MPH.0b013e3180437e02]
17. Ihaka R, Gentleman R. R: A Language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996; 5: 299-314 [
DOI:10.1080/10618600.1996.10474713]
18. Walter H, Farhud DD, Danker-Hopfe H, Amirshahi P. Investigations on the ethnic variability of the ABO blood group polymorphism in Iran. Z Morphol Anthropol 1991; 78: 289-306.
19. Grugni V, Battaglia V, Hooshiar Kashani B, Parolo S, Al-Zahery N, Achilli A, et al. Ancient migratory events in the Middle East: new clues from the Y-chromosome variation of modern Iranians. PLoS One 2012; 7: e41252. [
DOI:10.1371/journal.pone.0041252]
20. Saadat M, Ansari-Lari M, Farhud DD. Consanguineous marriage in Iran. Ann Hum Biol 2004; 31: 263-269. [
DOI:10.1080/03014460310001652211]
21. Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004; 329: 1134-1137. [
DOI:10.1136/bmj.329.7475.1134]
22. Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM. Results of the national program for prevention of beta-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin 2008; 32: 263-271. [
DOI:10.1080/03630260802004269]
23. Olwi D, Merdad L, Ramadan E. Knowledge of Genetics and Attitudes toward Genetic Testing among College Students in Saudi Arabia. Public Health Genomics 2016; 19: 260-268. [
DOI:10.1159/000446511]
24. Jallinoja P, Hakonen A, Aro AR, Niemela P, Hietala M, Lonnqvist J, et al. Attitudes towards genetic testing: analysis of contradictions. Soc Sci Med 1998; 46: 1367-1374. [
DOI:10.1016/S0277-9536(98)00017-3]
25. Roberts CD, Stough LD, Parrish LH. The role of genetic counseling in the elective termination of pregnancies involving fetuses with disabilities. J Spec Educ 2002; 36: 48-55. [
DOI:10.1177/00224669020360010501]
26. Oliveri S, Masiero M, Arnaboldi P, Cutica I, Fioretti C, Pravettoni G. Health orientation, knowledge, and attitudes toward genetic testing and personalized genomic services: preliminary data from an italian sample. Biomed Res Int 2016; 2016: 6824581. [
DOI:10.1155/2016/6824581]
27. Karimi M, Bonyadi M, Galehdari Mr, Zareifar S. Termination of pregnancy due to Thalassemia major, Hemophilia, and Down's syndrome: the views of Iranian physicians. BMC Med Ethics 2008; 9: 19. [
DOI:10.1186/1472-6939-9-19]
28. Bryant LD, Green JM, Hewison J. Prenatal screening for down's syndrome: some psychosocial implications of a 'screening for all' policy. Public Health 2001; 115: 356-358. [
DOI:10.1016/S0033-3506(01)00475-9]